Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
XLV has seen a sharp recovery in borrow availability this week, but the broader picture remains one of structurally elevated short positioning in the healthcare ETF.
The most notable development is in the lending market, where availability has improved materially from its recent extremes. On October 1, availability hit 3.4%, the tightest reading in the past 52 weeks, with virtually every share in the lending pool already lent out. By October 6, that had recovered to 32.6%, a three-fold loosening in five sessions. The cost to borrow has also fallen, dropping 19% on the week to 0.75%. Both moves suggest some short sellers covered positions, or new lending supply entered the market, after conditions became near-unsustainable at the start of the month.
Short interest, however, tells a more cautious story. Bears have not left. SI stands at 7.3% of free float as of October 6, up 3.4% on the week and up 27.5% over the past month. That monthly build is the more important figure: even accounting for the brief pullback in late September, shorts have added roughly a quarter of their positions since early September. The ORTEX short score sits at 60.8, a persistently elevated reading that has been range-bound between 60 and 62 for the past two weeks, signalling no meaningful shift in the broad bearish tilt. Options positioning reinforces this: the put/call ratio is at 1.65, running modestly above its 20-day average of 1.60, with a z-score near 0.8. That is not an extreme, but puts have dominated for weeks, consistent with investors hedging a continued sector drawdown rather than positioning for a bounce.
The price action reflects that backdrop. XLV closed at $167.09 on October 6, down 2.1% on the week and down 2.5% over the past month. That pullback comes after the September 11 rally to a 52-week high, when the ETF surged 2.1% on positive FDA decisions and defensive inflows. Since then, sentiment has rotated. The gains have been given back entirely, and the monthly chart now looks like a failed breakout rather than a sustained re-rating of the sector.
Institutional data, last reported as of June 30, shows Managed Account Advisors LLC as the largest disclosed holder at 9% of shares, with a modest addition last quarter. JPMorgan trimmed by 2.7 million shares in the same period, a reduction worth noting given the firm's scale. The data is three months old, so it is colour rather than a current signal, but the net picture heading into Q3 was mixed: some managers adding, others reducing.
What to watch next is whether the borrow availability recovery holds above 30%, or whether it compresses back toward the single digits seen earlier this month. If new short demand absorbs the lending supply that recently came back into the market, availability could tighten again quickly, given how far it has swung in both directions over just the past fortnight.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
